Conference Calls and Earnings Call Transcripts for NSE and BSE Stocks

Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans for NSE and BSE Stocks

announcement
Conference/Earnings Calls Alerts
Conference Call with Amber Enterprises India Ltd. Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
139.38
0.39%
Conference Call with Lemon Tree Hotels Ltd. Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
logo
Laurus Labs Ltd.
09 Nov 2020
605.95
1.80%
388.50
1.53%
RAMCO SYSTEMS LTD. - 532370 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Further to our intimation dated November 03, 2020, regarding analyst/ investors call, please find enclosed the gist of the points/ presentation and the fact sheet discussed in the Con-Call held on 04th November 2020. The aforesaid intimation is also being hosted on the website of the Company www.ramco.com.
318.10
4.43%
1418.40
1.01%
Conference Call with Ipca Laboratories Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
208.15
2.69%
Conference Call with Greaves Cotton Ltd. Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
234.53
1.82%
Conference Call with Ashok Leyland Ltd. Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.
RATNAMANI METALS & TUBES LTD.-$ - 520111 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet …
BSE India
Dear Sir/Madam, Please note that we had vide our letter dated 2nd November, 2020 intimated to the Stock Exchanges about the schedule of Investor Conference Call on Wednesday, 4th November, 2020 on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended on 30th September, 2020. We enclose a copy of Transcript of the Investor Conference Call which took place on 4th November, 2020. The said transcript has also been uploaded on the Company's website. Kindly take the above on your record.
1442.90
1.80%
Conference Call with Glenmark Pharmaceuticals Ltd. Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.

Earnings Calls Podcast on